SYK and cancer: This led to the SHP2-dependent dephosphorylation of Src and OTUB1 (Fig. 6A, D), and ODN-induced Syk activation increased sensitivity to the anti-cancer drug through regulation of SHP2/OTUB1/Raptor axis (Fig. 6H).